A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

COVID-19 antivirals, specifically, have become hard to access for some patients. Many requirements accompany the distribution of the drugs to patients, and for a good reason. Accessing antivirals ...

9 9 Lin Y, Wu F, Xie Z, et al. Clinical study of artesunate in the treatment of coronavirus disease 2019. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2020;32(4):417-20. Chinese. The current prospective ...

Symptoms of viruses like COVID and flu overlap with each other, but there are ways you can narrow it down to get the ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution (16 vs 19 days; HR, 1.20) through 28 days and cut the number of ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

XBB.1.5 shots—reduced the risk of severe COVID-19 by 31%, and the use of antiviral drugs reduced the risk of severe disease by 42%. The findings come on the tail of research from the Centers for ...

Flu has a different treatment than COVID-19, but antivirals for either should be started immediately. RSV is a common virus that causes only mild symptoms in most adults, such as a runny nose ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...